B
L. E. Bermudez, Parker, A., and Goodman, J. R.,
“Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway.”,
Infection and immunity, vol. 65, no. 5, pp. 1916-25, 1997.
L. E. Bermudez, Nash, K. A., Petrofsky, M., Young, L. S., and Inderlied, C. B.,
“Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.”,
The Journal of infectious diseases, vol. 174, no. 6, pp. 1218-22, 1996.
L. E. Bermudez, Wu, M., Petrofsky, M., and Young, L. S.,
“Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.”,
Infection and immunity, vol. 60, no. 10, pp. 4245-52, 1992.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S.,
“Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.”,
Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.
L. E. Bermudez, Wu, M., and Young, L. S.,
“Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin.”,
The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.
L. E. Bermudez and Inderlied, C. B.,
“Effect of Mycobacterium avium infection on the influx, accumulation, and efflux of KRM-1648 by human macrophages.”,
Microbial drug resistance (Larchmont, N.Y.), vol. 3, no. 3, pp. 277-82, 1997.
L. E. Bermudez, Petrofsky, M., Inderlied, C. B., and Young, L. S.,
“Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice.”,
The Journal of antimicrobial chemotherapy, vol. 36, no. 4, pp. 641-6, 1995.
L. E. Bermudez, Parker, A., and Petrofsky, M.,
“Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases.”,
Clinical and experimental immunology, vol. 116, no. 1, pp. 94-9, 1999.
L. E. Bermudez,
“Potential role of cytokines in disseminated mycobacterial infections.”,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13 Suppl 2, pp. S29-33, 1994.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Chee, C. B., Aralar, P., Petrofsky, M., Parman, T., Green, C. E., Lewin, A. H., Ellis, W. Y., and Young, L. S.,
“Identification of (+)-Erythro-Mefloquine as an Active Enantiomer with Greater Efficacy than Mefloquine against Mycobacterium avium Infection in Mice.”,
Antimicrobial agents and chemotherapy, vol. 56, no. 8, pp. 4202-6, 2012.
L. E. Bermudez,
“[Bacteremias in immunosuppressed patients].”,
Revista paulista de medicina, vol. 104, no. 2, pp. 87-92, 1986.
L. E. Bermudez, Petrofsky, M., Sommer, S., and Barletta, R. G.,
“Peyer's patch-deficient mice demonstrate that Mycobacterium avium subsp. paratuberculosis translocates across the mucosal barrier via both M cells and enterocytes but has inefficient dissemination.”,
Infection and immunity, vol. 78, no. 8, pp. 3570-7, 2010.
L. E. Bermudez, Young, L. S., and Enkel, H.,
“Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins.”,
Infection and immunity, vol. 59, no. 5, pp. 1697-702, 1991.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S.,
“Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.”,
Antimicrobial agents and chemotherapy, vol. 42, no. 1, pp. 180-3, 1998.
L. E. Bermudez, Martinelli, J., Petrofsky, M., Kolonoski, P., and Young, L. S.,
“Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.”,
The Journal of infectious diseases, vol. 169, no. 3, pp. 575-80, 1994.